James R Bridgeman, APRN | |
1710 Harrison St, Batesville, AR 72501-7303 | |
(870) 262-1200 | |
Not Available |
Full Name | James R Bridgeman |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 1710 Harrison St, Batesville, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396394060 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 122101 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
White River Medical Center | Batesville, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
White River Health System Inc | 0143134270 | 150 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568442127 PECOS PAC ID: 0143134270 Enrollment ID: O20060221000012 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457396616 PECOS PAC ID: 0143134270 Enrollment ID: O20060830000031 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871609743 PECOS PAC ID: 0143134270 Enrollment ID: O20070223000663 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467519249 PECOS PAC ID: 0143134270 Enrollment ID: O20070503000423 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477523348 PECOS PAC ID: 0143134270 Enrollment ID: O20110510000339 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962482430 PECOS PAC ID: 0143134270 Enrollment ID: O20110614000786 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760452643 PECOS PAC ID: 0143134270 Enrollment ID: O20111003000187 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578543070 PECOS PAC ID: 0143134270 Enrollment ID: O20120725000268 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962878207 PECOS PAC ID: 0143134270 Enrollment ID: O20160318001395 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104275486 PECOS PAC ID: 0143134270 Enrollment ID: O20170119000552 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013451186 PECOS PAC ID: 0143134270 Enrollment ID: O20170125002953 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154770436 PECOS PAC ID: 0143134270 Enrollment ID: O20170216001323 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
James R Bridgeman, APRN Po Box 42, Thida, AR 72165-0042 Ph: (870) 612-0806 | James R Bridgeman, APRN 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1200 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.
› Verified 8 days ago
Mr. Leroy Maupin Jr., APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4200 Fax: 870-698-1353 | |
Angela Burleson, MS, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 202, Batesville, AR 72501 Phone: 870-262-2000 | |
Rachel Jeannette Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 905 20th St Ste B, Batesville, AR 72501 Phone: 870-569-4942 Fax: 870-569-4943 | |
Mrs. Michelle Lee Hagen, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6199 | |
Cynthia Elaine Jackson, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3443 Harrison St, Batesville, AR 72501 Phone: 870-698-1635 Fax: 870-612-3389 | |
Brandy M Moore, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 255 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4300 | |
Robin Kerr, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 |